Jeff Berkowitz, CEO & Director of Real Endpoints

Jeff Berkowitz’s perspective has been shaped by a career spanning most key verticals in healthcare and the drug supply chain with executive committee and other senior roles at UnitedHealth Group, Walgreens Boots Alliance and Merck. Jeff, a lawyer by training, is a recognized expert and thought leader in market access and reimbursement for pharmaceuticals and serves on the Board of Directors of a number of publicly traded pharmaceutical companies including Lundbeck A/S, Esperion Therapeutics, and Zealand Pharmaceuticals, and is also on the board of the drug distributor Uniphar.

Jeff is currently the CEO of Real Endpoints, a leader in providing insights, support and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape with a concentrated focus on value-based arrangements, patient services and access and pricing support for manufacturers and payers.